DWJ211

· Daewoong Pharmaceutical Co. LTD.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DWJ211, covering 2024-04-04 to 2024-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat [Phase 3]